Bonefos and the Consumption of Analgesics
NCT00909142 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 149
Last updated 2012-04-06
Summary
The effect of Bonefos on consumption of analgesics (drugs used for pain treatment) in patients with proven bone metastases.
Conditions
- Bone Neoplasms
Interventions
- DRUG
-
Bonefos (Clodronate, BAY94-8393)
Patients in regular clinical practice receiving Bonefos according to local drug information
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-04-30
- Primary Completion
- 2009-02-28
- Completion
- 2009-02-28
Countries
- Czechia
More Related Trials
-
Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain
NCT00101621 ·Status: TERMINATED ·Phase: PHASE2
-
Individualized Pharmaceutical-care in Outpatients With Cancer Pain
NCT03439904 ·Status: UNKNOWN ·Phase: NA
-
Observational Registry Study of Quality of Life When Treating BTcP With Abstral
NCT01936636 ·Status: COMPLETED
-
Individualized Pharmaceutical-care for Inpatients With Cancer Pain
NCT03455023 ·Status: UNKNOWN ·Phase: NA
-
Effect of Guanfacine on Opioid-induced Hyperalgesia (OIH) and Tolerance
NCT01681264 ·Status: TERMINATED ·Phase: PHASE4
-
Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain
NCT01946555 ·Status: COMPLETED
-
Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH)
NCT02192398 ·Status: TERMINATED ·Phase: NA
-
A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast Cancer
NCT02553707 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain
NCT03176121 ·Status: COMPLETED ·Phase: PHASE4
-
Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain
NCT00911261 ·Status: COMPLETED ·Phase: PHASE3
-
Diamorphine or Alfentanil for Subcutaneous Use in Hospice In-patients?
NCT01049672 ·Status: COMPLETED ·Phase: NA
-
Long-term Effects of Methadone for Cancer Pain
NCT02856399 ·Status: UNKNOWN
-
Correlation Between the Analgesic Effect of Fentanyl Transdermal Patches and Nutritional Status in Cancer Pain Patients
NCT06369961 ·Status: COMPLETED
-
Efficacy of Low Analgesic Doses of Ketamine Associated With Opioids in Refractory Cancer Pain Treatment
NCT01326325 ·Status: COMPLETED ·Phase: PHASE3
-
Real World Study of Oxycodone Sustained-release Tablets for Patients With Moderate to Severe Cancer Pain
NCT05962294 ·Status: UNKNOWN
-
Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning
NCT00930943 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain
NCT00214942 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients.
NCT00410540 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)
NCT00095017 ·Status: WITHDRAWN ·Phase: PHASE2
-
Oral Piroxicam Versus Buccal Fentanyl in Breakthrough Pain
NCT02382653 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer
NCT01842893 ·Status: COMPLETED ·Phase: PHASE3
-
Metamizol for the Treatment of Neoplastic Chronic Pain
NCT02181920 ·Status: TERMINATED ·Phase: PHASE4
-
Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients (FT-017-IM)
NCT00345735 ·Status: COMPLETED ·Phase: PHASE2
-
Cessation of Long-term Opioid Therapy in Chronic Pain Patients
NCT02132221 ·Status: TERMINATED ·Phase: NA
-
Prospective Multicentre Study of the Use of Ketamine in the Treatment of Refractory Chronic Pain in the French CLCC
NCT04459234 ·Status: COMPLETED